Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma

Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma

BackgroundImmunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking.MethodsFerroptosis-related genes (FRGs) were ident...

Full description

Bibliographic Details
Main Authors: Yang Liu, Xi Zhang, Junjun Zhang, Juan Tan, Jie Li, Zewen Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
ferroptosis
immune
hepatocellular carcinoma
prognosis
personalized therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/full

Similar Items